Form 8-K - Current report:
SEC Accession No. 0001144204-15-002130
Filing Date
2015-01-14
Accepted
2015-01-14 09:00:32
Documents
2
Period of Report
2015-01-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v398709_8k.htm 8-K 15363
2 GRAPHIC image_001.jpg GRAPHIC 3947
  Complete submission text file 0001144204-15-002130.txt   22191
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 15526178
SIC: 2834 Pharmaceutical Preparations